ESR1 and breast carcinoma: A large-scale meta-analysis performed on 31 breast cancer profiling datasets has revealed over expression of the AT1 receptor gene (AGTR1) in 10–20% of invasive breast tumors (Rhodes et al., 2009), all of which were estrogen receptor positive (ER+) and human epidermal receptor 2 (HER2)-negative.